Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03532191 · ClinicalTrials.gov registry record · NA
Improving the HIV PrEP Cascade Using an Intervention for Healthcare Providers
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT03532191 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 10 participants.
The verdict
NCT03532191, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The PrEP Optimization Intervention (PrEP-OI) aims to educate healthcare providers on PrEP and assist providers in the appropriate targeting of patients at increased risk for HIV acquisition, initiating PrEP when appropriate, and providing guidance on the ongoing monitoring and adherence counseling of patients on PrEP. The intervention includes a web-based panel management tool (called PrEP-Rx) and PrEP coordination (by a PrEP Coordinator). The PrEP-OI study will take place among participating primary care and specialty clinics across the San Francisco Department of Public Health.
Interventions
- OTHER PrEP Optimization Intervention (PrEP-OI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-11-01 |
| Est. Completion | 2021-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03532191
The ClinicalTrials.gov registry entry for NCT03532191 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PrEP Optimization Intervention (PrEP-OI) is the first listed.
NCT03532191 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03532191 about?
NCT03532191 is a clinical study titled "Improving the HIV PrEP Cascade Using an Intervention for Healthcare Providers". The PrEP Optimization Intervention (PrEP-OI) aims to educate healthcare providers on PrEP and assist providers in the appropriate targeting of patients at increased risk for HIV acquisition, initiating PrEP when appropriate, and providing guidance on the ongoing monitoring and adherence counseling o...
What is the current status of trial NCT03532191?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2018-11-01. Estimated completion is 2021-01-31.
What interventions are being tested in trial NCT03532191?
The interventions under investigation include: PrEP Optimization Intervention (PrEP-OI) (OTHER).
Who is sponsoring clinical trial NCT03532191?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.